Impact of the flu mask regulation on health care personnel influenza vaccine acceptance rates

Edwards, Frances L.; Masick, Kevin D.; Armellino, Donna

doi:10.1016/j.ajic.2016.03.006

Cited by 5 publications

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Plusieurs initiatives ont été évaluées pour améliorer cette couverture vaccinale dont la mise à disposition gratuite du vaccin et un accès simple au vaccin sur le lieu de travail [130]. Récemment, l'obligation de porter un masque pour les soignants non vaccinés a été associée à une nette augmentation de la couverture vaccinale, les soignants rapportaient préférer la vaccination à l'inconfort du masque [131,132].…”

Section: Les Vaccins Disponibles à Destination Des Soignantsunclassified

Les vaccins dans la prévention des infections associées aux soins

Gagneux‐Brunon

Lucht

Launay

et al. 2017

Journal des Anti-infectieux

View full text Add to dashboard Cite

Section: Les Vaccins Disponibles à Destination Des Soignantsunclassified

Les vaccins dans la prévention des infections associées aux soins

Gagneux‐Brunon

Lucht

Launay

et al. 2017

Journal des Anti-infectieux

View full text Add to dashboard Cite

Commentary on reasons for influenza vaccination underuse: A case–control study

Hutchins

2017

American Journal of Infection Control

View full text Add to dashboard Cite

After the introduction of the phlebotomist team, there was a reduction of samples discarded because of incorrect technique or route of collection, from 54 to only 4 after the intervention (P < .001). When evaluating contamination, 98 contaminated blood cultures were recorded before the intervention, establishing a baseline rate of 12.48% (98/785). With the work of technicians, the number of contaminated blood cultures was 67, leading to a rate of 7.9% (67/848). The intervention with the phlebotomist team significantly reduced the contamination rate (P = .002). Regarding culture site, 2 blood cultures in the postintervention period had no indication of the collection site and were not accounted for in the following analysis. Throughout the 13-month period analyzed in the study, 58.4% (953/1,633) of the blood cultures were collected in intensive care units and corresponded to 74.8% (122/163) of all contaminations. When comparing the respective contamination rates of each site, the reduction in the overall contamination rate was because of a significant reduction in the contamination of samples collected in intensive care units, which were reduced from 17.24% (75/435) to 9.07% (47/518) and presented statistical significance (P < .001). Single blood cultures corresponded to 5.73% of the total valid samples (205/ 3,579), and there was no significant change in their total amount between the analyzed periods (P = .144). Although they were disregarded for the contamination rate calculation, a reduction was observed in samples classified as possibly contaminated, which went from 17 to 4 (P = .005). The use of a phlebotomy team, associated with an educational intervention, can significantly reduce the blood culture contamination rate, especially in sites with a history of high contamination, such as intensive care units.

show abstract

Vaccines for healthcare-associated infections: present, future, and expectations

Gagneux‐Brunon

Lucht

Launay

et al. 2018

Expert Review of Vaccines

View full text Add to dashboard Cite

In spite of the widespread implementation of preventive strategies, the prevalence of healthcare-associated infections (HAIs) remains high. HAIs are associated with multidrug resistant organisms, and in the post-antibiotic era, alternative strategies such as vaccines are needed for their management. Areas covered: Vaccines to prevent HAIs could be proposed to at-risk patients, or to healthcare workers (HCWs) to prevent cross-transmission. After searches in Pubmed and clinicaltrials.gov, existing vaccines and vaccines under clinical development are presented in this narrative review. Issues associated with the use of vaccines to prevent HAIs are discussed. Expert commentary: Future vaccines against HAIs will contribute to fight antibiotic resistance and thus reduce the burden of HAIs. At this stage, the goal of obtaining effective vaccines against S.aureus, C. difficile and gram-negative bacteria has not yet been achieved. Obtaining an efficient response to vaccines in at-risk patients for HAIs is also challenging, and future strategies of vaccination need to address this difficulty. The efficacy of vaccines for HCWs in reducing the spread of nosocomial outbreaks is counterbalanced by the lack of adherence to vaccine policies among HCWs. The acceptance of future vaccines to prevent carriage and infection with organisms involved in HAIs in HCWs will probably be a challenge.

show abstract

Impact of the flu mask regulation on health care personnel influenza vaccine acceptance rates

Cited by 5 publications

References 10 publications

Les vaccins dans la prévention des infections associées aux soins

Les vaccins dans la prévention des infections associées aux soins

Commentary on reasons for influenza vaccination underuse: A case–control study

Vaccines for healthcare-associated infections: present, future, and expectations

Contact Info

Product

Resources

About